Claims Accusing Medtronic of Promoting Off-Label Use of Infuse Not Preempted, Ariz. Federal Judge Rules
August 26, 2013
DOCUMENTS
- Order
PHOENIX — State law claims accusing Medtronic of improperly promoting the off-label use of its bone graft device are not preempted because they stand independently of federal regulations, an Arizona federal judge has ruled.
In an Aug. 21 order, Judge G. Murray Snow of the U.S. District Court for the District of Arizona explained that when the device is not being used in an FDA-approved manner and the manufacturer is actually promoting such use, there is no law or policy basis on which to preempt the application of state law designed to provide that protection.
On March 2, 2009, …
FIRM NAMES
- Leiff Cabraser Heimann & Bernstein
- Lewis & Roca
- Reed Smith
- Stark Williamson & Clausen
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick